Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Blinded, Clinical Study for Assessing the Effectiveness of the NeuroSENSE for Monitoring the Hypnotic Depth of Anesthesia (DOA)

NCT02088671 is registered in ClinicalTrials.gov with NeuroWave Systems Inc. as lead sponsor.

NCT NCT02088671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02088671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Blinded, Clinical Study for Assessing the Effectiveness of the NeuroSENSE for Monitoring the Hypnotic Depth of Anesthesia (DOA)
Lead sponsor
NeuroWave Systems Inc.
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
October 31, 2016
Enrollment
76 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depth of anesthesia (doa)